| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TRxADE HEALTH, INC | Director | Common stock | 65.4K | $70.7K | $1.08 | Sep 1, 2022 | Direct |
| ORAGENICS INC | Director | Non-Employee Director Option (Right to Buy) | 100K | Sep 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OGEN | ORAGENICS INC | Sep 19, 2024 | 1 | $0 | 4 | Sep 20, 2024 | Director |
| OGEN | ORAGENICS INC | Aug 8, 2023 | 1 | $0 | 4 | Aug 10, 2023 | Director |
| MEDS | TRxADE HEALTH, INC | Sep 1, 2022 | 1 | $0 | 4 | Sep 16, 2022 | Director |
| OGEN | ORAGENICS INC | Jul 29, 2022 | 1 | $0 | 4 | Aug 2, 2022 | Director |
| OGEN | ORAGENICS INC | Dec 16, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
| MEDS | TRxADE HEALTH, INC | May 27, 2021 | 1 | $41.2K | 4 | Jun 2, 2021 | Director |
| MEDS | TRxADE HEALTH, INC | May 27, 2021 | 0 | $0 | 3 | Jun 2, 2021 | Director |